Related Experiment Video
Updated: May 18, 2026

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
A retrospective, matched-tool comparison of the opioid risk tool and revised opioid risk tool in community pharmacy
Background:
The Opioid Risk Tool (ORT) was compared with the Revised Opioid Risk Tool (ORT-R) in a large community pharmacy population. The ORT-R removes the preadolescent sexual abuse (PSA) item and sex-based scoring weights used in the original ORT.
Objective:
To compare opioid risk classification between the ORT and ORT-R in community pharmacy screenings, with a focus on reclassification patterns, PSA-related sex differences, and agreement between tools.
Methods:
A retrospective, matched-tool comparison was conducted among 21,295 patients screened with the ORT in community pharmacy settings. Identical patient data were rescored using the ORT-R. Descriptive analyses summarized overall distributions, reclassification patterns, and PSA-related sex differences. Because no external clinical outcomes were available, measures of predictive performance such as sensitivity and specificity could not be assessed.
Results:
A total of 90.7% and 93.4% of participants were classified as low risk on the ORT and ORT-R, respectively. The ORT-R produced modest shifts in classification. Approximately 6% of patients classified as moderate on the ORT were reclassified as either low or high risk on the ORT-R. Nearly 80% of women with PSA histories were reassigned under the ORT-R, reflecting the structural removal of the PSA item from scoring, compared with fewer than half of men. The factors most strongly associated with reclassification were family (odds ratio [OR] 16.21, confidence interval [CI] 13.82-19.02) or personal alcohol abuse (OR 6.04, CI (4.85-7.52), depression (OR 4.64, CI 3.99-5.39), and psychiatric disease (OR 4.41, CI 3.63-5.36).
Conclusion:
These findings suggest potential sex-based differences associated with PSA weighting in the ORT. In the ORT, PSA contributes to scoring for women but not for men, and the item may also trigger survivors during pharmacy-based screening. The ORT-R may represent a simpler scoring approach with similar overall classification patterns, though outcome-based validation is needed.
Related Concept Videos
Odds Ratio
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Toxicity: Risk factors
Receiver Operating Characteristic Plot
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

